News

Filter

Current filters:

None

95815 to 95824 of 97511 results

Biomira Inc formal approval for Tru-Scint Trials

22-06-1992

Biomira Inc reported that it has recieved formal approval to start clinical trials of Tru -Scint, , its…

1991 "BETTER THAN EXPECTED" AT SCHERING

22-06-1992

Business in 1991 turned out to be better than expected at Schering AG of Berlin, Germany, and the company…

FludaraFludarabineGadopentetate DimeglumineMagnevistNystatinOralSchering Ag

HEP B VACCINATION:UK POLICY INEFFECTIVE

22-06-1992

Despite the existence of an effective vaccine, hepatitis B remains a major public health problem in the…

BBG'S NEW CANCER DRUG ENTERS TRIALS

22-06-1992

A Phase I/II clinical trial of British Bio-technology Group's novel broad spectrum matrix metalloproteinase…

NystatinOral

FIRST EC LAUNCH OF DIDANOSINE

22-06-1992

Bristol-Myers Squibb has launched its anti-AIDS drug Videx (didanosine) in France, the first European…

Bristol-Myers SquibbDidanosine Pediatric Powder for Oral SolutionRetrovirVidexZidovudine

FLAT GROWTH FOR ISRAELI DRUGMAKERS

22-06-1992

Only three pharmaceutical companies in Israel have shown a growth rate in excess of 20% in the first…

EC "CITIZENS'" CONCERN OVER MEDICAL ETHICS

22-06-1992

Following the recent European Commission-funded "citizens' audit" of biotechnology (Market-letter, June…

ECONOMICS AND HEALTH SECTOR ANALYSIS

22-06-1992

The World Bank has produced a new manual for health care professionals in developing countries, introducing…

NystatinOral

95815 to 95824 of 97511 results

Back to top